Status:
UNKNOWN
Antenatal Allopurinol During Fetal Hypoxia
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Fetal Hypoxia
Reperfusion Injury
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
A former study (submitted) in 32 severely asphyxiated infants participating in a randomized double blind study, in which early postnatal allopurinol or a placebo (within 4 hours after birth) was admin...
Eligibility Criteria
Inclusion
- Gestational age of 36 weeks or more
- Non-reassuring CTG, significant events on the STAN-monitor AND/OR FBS \< 7.20
Exclusion
- Chromosomal abnormalities
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
222 Patients enrolled
Trial Details
Trial ID
NCT00189007
Start Date
October 1 2009
End Date
December 1 2016
Last Update
March 29 2012
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilhelmina Children's Hospital/UMC Utrecht
Utrecht, Utrecht, Netherlands, 3508AB
2
Jeroen Bosch Hospital
's-Hertogenbosch, Netherlands
3
AMC
Amsterdam, Netherlands
4
VUmc
Amsterdam, Netherlands